Drugs / sacubitril/valsartan
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04929600 | Nov 2021 → Jun 2023 | essential hypertension | Shanghai Jiao Tong University School of Medicine | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sacubitril/valsartan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04929600 ↗ |
| Route | Oral | “Sacubitril/valsartan oral tablets (200mg)” NCT04929600 ↗ |